How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview
Crossref DOI link: https://doi.org/10.1007/s12325-019-00971-0
Published Online: 2019-05-17
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Empeslidis, Theodoros
Storey, Matthew
Giannopoulos, Theodoros
Konidaris, Vassileios
Tranos, Paris G.
Panagiotou, Evangelia S.
Voudouragkaki, Irini C.
Konstas, Anastasios G.
Text and Data Mining valid from 2019-05-17
Version of Record valid from 2019-05-17
Article History
Received: 8 January 2019
First Online: 17 May 2019